AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.69 Cr | ₹-2.17 Cr | ₹-0.76 Cr | ₹-14 Cr | ₹13 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AARTI DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹2.69 Cr |
| Mar2025 | ₹-2.17 Cr |
| Mar2024 | ₹-0.76 Cr |
| Mar2023 | ₹-14 Cr |
| Mar2022 | ₹13 Cr |
How is Net Cash Inflow / Outflow of AARTI DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.69 Cr | Positive | |
| Mar2025 | ₹-2.17 Cr | Negative | |
| Mar2024 | ₹-0.76 Cr | Negative | |
| Mar2023 | ₹-14 Cr | Negative | |
| Mar2022 | ₹13 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,651.3 Cr | 14.1% | 24.1% | 0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 14.1% |
24.1% |
0.2% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses